 |
 |

Overrides of Medication Alerts in Ambulatory Care
Thomas Isaac, MD, MBA, MPH;
Joel S. Weissman, PhD;
Roger B. Davis, ScD;
Michael Massagli, PhD;
Adrienne Cyrulik, MPH;
Daniel Z. Sands, MD, MPH;
Saul N. Weingart, MD, PhD
Arch Intern Med. 2009;169(3):305-311.
Background Electronic prescribing systems with decision support may improve patient safety in ambulatory care by offering drug allergy and drug interaction alerts. However, preliminary studies show that clinicians override most of these alerts.
Methods We performed a retrospective analysis of 233 537 medication safety alerts generated by 2872 clinicians in Massachusetts, New Jersey, and Pennsylvania who used a common electronic prescribing system from January 1, 2006, through September 30, 2006. We used multivariate techniques to examine factors associated with alert acceptance.
Results A total of 6.6% of electronic prescription attempts generated alerts. Clinicians accepted 9.2% of drug interaction alerts and 23.0% of allergy alerts. High-severity interactions accounted for most alerts (61.6%); clinicians accepted high-severity alerts slightly more often than moderate- or low-severity interaction alerts (10.4%, 7.3%, and 7.1%, respectively; P < .001). Clinicians accepted 2.2% to 43.1% of high-severity interaction alerts, depending on the classes of interacting medications. In multivariable analyses, we found no difference in alert acceptance among clinicians of different specialties (P = .16). Clinicians were less likely to accept a drug interaction alert if the patient had previously received the alerted medication (odds ratio, 0.03; 95% confidence interval, 0.03-0.03).
Conclusion Clinicians override most medication alerts, suggesting that current medication safety alerts may be inadequate to protect patient safety.
Author Affiliations: Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center (Drs Isaac, Davis, Sands, and Weingart), Institute for Health Policy, Massachusetts General Hospital (Dr Weissman), Blue Cross Blue Shield of Massachusetts (Ms Cyrulik), Center for Patient Safety, Dana-Farber Cancer Institute (Drs Isaac and Weingart), and Department of Medicine, Harvard Medical School (Drs Isaac, Weissman, Davis, Sands, and Weingart), Boston; PatientsLikeMe Inc, Cambridge, Massachusetts (Dr Massagli); and Cisco Systems, San Jose, California (Dr Sands).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED LETTER
Overrides of Medication Alerts in Ambulatory Care
Stephen N. Rosenberg, Maureen Sullivan, Iver A. Juster, and Jeffrey Jacques
Arch Intern Med. 2009;169(14):1337.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Alert fatigue
Cash
Am J Health Syst Pharm 2009;66:2098-2101.
FULL TEXT
Clinicians' Assessments of Electronic Medication Safety Alerts in Ambulatory Care
Weingart et al.
Arch Intern Med 2009;169:1627-1632.
ABSTRACT
| FULL TEXT
An Empirical Model to Estimate the Potential Impact of Medication Safety Alerts on Patient Safety, Health Care Utilization, and Cost in Ambulatory Care
Weingart et al.
Arch Intern Med 2009;169:1465-1473.
ABSTRACT
| FULL TEXT
Overrides of Medication Alerts in Ambulatory Care
Rosenberg et al.
Arch Intern Med 2009;169:1337-1337.
FULL TEXT
Consider the Content of Drug-Drug Interaction Alerts
Sweidan et al.
Arch Intern Med 2009;169:1338-1338.
FULL TEXT
|